Artykuły udostępnione publicznie: - Rodrigo Machado-VieiraWięcej informacji
Niedostępne w żadnym miejscu: 8
Bias in emerging biomarkers for bipolar disorder
AF Carvalho, CA Köhler, BS Fernandes, J Quevedo, KW Miskowiak, ...
Psychological medicine 46 (11), 2287-2297, 2016
Upoważnienia: National Health and Medical Research Council, Australia
Familial aggregation and heritability of the melancholic and atypical subtypes of depression
F Lamers, L Cui, IB Hickie, C Roca, R Machado-Vieira, CA Zarate Jr, ...
Journal of Affective Disorders 204, 241-246, 2016
Upoważnienia: US National Institutes of Health
The role of lithium treatment on comorbid anxiety symptoms in patients with bipolar depression
G Jones, C Rong, CM Vecera, CI Gurguis, R Chudal, R Khairova, ...
Journal of affective disorders 308, 71-75, 2022
Upoważnienia: Fundação de Amparo à Pesquisa do Estado de São Paulo
Lithium increases cortical and subcortical volumes in subjects with bipolar disorder
G Jones, R Suchting, MV Zanetti, E Leung, SC da Costa, RT de Sousa, ...
Psychiatry Research: Neuroimaging 324, 111494, 2022
Upoważnienia: Fundação de Amparo à Pesquisa do Estado de São Paulo
1003. Acute Ketamine Administration Corrects Abnormal Inflammatory Bone Markers in Major Depression
B Kadriu, P Gold, M Lener, E Ballard, M Niciu, P Yuan, D Luckenbaugh, ...
Biological Psychiatry 81 (10), S405-S406, 2017
Upoważnienia: US National Institutes of Health
80. Theories on the Mechanism of Action of Ketamine: From NMDA Receptor Inhibition to the (2R, 6R)-HNK Metabolite
C Zarate, T Gould, P Zanos, R Machado-Vieira
Biological Psychiatry 81 (10), S33-S34, 2017
Upoważnienia: US National Institutes of Health
Mood Stabilizers
G Chen, R Machado-Vieira, CA Zarate, HK Manji
Encyclopedia of Molecular Pharmacology, 1004-1010, 2022
Upoważnienia: US National Institutes of Health
Original Research Clinical Predictors of Ketamine Response
MJ Niciu, DA Luckenbaugh, DF Ionescu, S Guevara, R Machado-Vieira, ...
J Clin Psychiatry 75 (5), e417-e423, 2014
Upoważnienia: US National Institutes of Health
Dostępne w jakimś miejscu: 113
A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression
N Diazgranados, L Ibrahim, NE Brutsche, A Newberg, P Kronstein, ...
Archives of general psychiatry 67 (8), 793-802, 2010
Upoważnienia: US National Institutes of Health
Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group
DP Hibar, LT Westlye, NT Doan, N Jahanshad, JW Cheung, CRK Ching, ...
Molecular psychiatry 23 (4), 932-942, 2018
Upoważnienia: US National Institutes of Health, National Health and Medical Research …
Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder
N DiazGranados, LA Ibrahim, NE Brutsche, R Ameli, ID Henter, ...
The Journal of clinical psychiatry 71 (12), 16899, 2010
Upoważnienia: US National Institutes of Health
Dynamic regulation of mitochondrial function by glucocorticoids
J Du, Y Wang, R Hunter, Y Wei, R Blumenthal, C Falke, R Khairova, ...
Proceedings of the National Academy of Sciences 106 (9), 3543-3548, 2009
Upoważnienia: US National Institutes of Health
A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder
RA Khairova, R Machado-Vieira, J Du, HK Manji
International Journal of Neuropsychopharmacology 12 (4), 561-578, 2009
Upoważnienia: US National Institutes of Health
The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis
R Machado‐Vieira, HK Manji, CA Zarate Jr
Bipolar disorders 11, 92-109, 2009
Upoważnienia: US National Institutes of Health
Ketamine and the next generation of antidepressants with a rapid onset of action
R Machado-Vieira, G Salvadore, N DiazGranados, CA Zarate Jr
Pharmacology & therapeutics 123 (2), 143-150, 2009
Upoważnienia: US National Institutes of Health
Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies
BS Fernandes, ML Molendijk, CA Köhler, JC Soares, CMGS Leite, ...
BMC medicine 13, 1-22, 2015
Upoważnienia: US National Institutes of Health, National Health and Medical Research …
Glutamatergic modulators: the future of treating mood disorders?
C Zarate, R Machado-Vieira, I Henter, L Ibrahim, N Diazgranados, ...
Harvard review of psychiatry 18 (5), 293-303, 2010
Upoważnienia: US National Institutes of Health
Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression
L Ibrahim, N Diazgranados, DA Luckenbaugh, R Machado-Vieira, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (4), 1155-1159, 2011
Upoważnienia: US National Institutes of Health
Novel insights into lithium’s mechanism of action: neurotrophic and neuroprotective effects
JA Quiroz, R Machado-Vieira, CA Zarate, Jr, HK Manji
Neuropsychobiology 62 (1), 50-60, 2010
Upoważnienia: US National Institutes of Health
The neurobiology of the switch process in bipolar disorder: a review
G Salvadore, JA Quiroz, R Machado-Vieira, ID Henter, HK Manji, ...
The Journal of clinical psychiatry 71 (11), 12633, 2010
Upoważnienia: US National Institutes of Health
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy